Episode

GLP-1s and the ‘Wild West’ of Wellness

Podcast
The Ezra Klein Show
Published
May 8, 2026
Duration seconds
4437
Processing state
not_requested
Canonical source
https://www.nytimes.com/2026/05/08/opinion/ezra-klein-podcast-julia-belluz.html
Audio
https://dts.podtrac.com/redirect.mp3/pdst.fm/e/pfx.vpixl.com/6qj4J/pscrb.fm/rss/p/nyt.simplecastaudio.com/3026b665-46df-4d18-98e9-d1ce16bbb1df/episodes/0ce18780-f0dd-4bc7-ba37-13b83d611046/audio/128/default.mp3?aid=rss_feed&awCollectionId=3026b665-46df-4d18-98e9-d1ce16bbb1df&awEpisodeId=0ce18780-f0dd-4bc7-ba37-13b83d611046&feed=82FI35Px
JSON
/v1/public/podcasts/the-ezra-klein-show-1371595/episodes/glp-1s-and-the-wild-west-of-wellness
Markdown
/podcast/the-ezra-klein-show-1371595/glp-1s-and-the-wild-west-of-wellness.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-ezra-klein-show-1371595/episodes/glp-1s-and-the-wild-west-of-wellness/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-ezra-klein-show-1371595/glp-1s-and-the-wild-west-of-wellness.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Here’s a shocking number: One out of eight American adults is taking a GLP-1, like Ozempic or Zepbound, according to a KFF poll. GLP-1s are the biggest pharmaceutical story since antidepressants. But there’s still so much we don’t know. “We’re only at the beginning of what’s been called this Ozempic era,” the journalist Julia Belluz told me. “I think we’re really just at the beginning of discovering the benefits and the harms of these drugs.” These discoveries begin in the research but are also expanding into how we think about our punishing beauty standards and the blurry lines between illness and wellness. Belluz is a contributing Opinion writer and the author, with Kevin Hall, of “Food Intelligence.” She’s one of the best health and science reporters I know and has been reporting on GLP-1s for years. In this conversation, Belluz takes me through what we know — and don’t know — about GLP-1s, their unexpected uses, how they are clashing with a culture obsessed with thinness and looksmaxxing, and whether everyone should be on them. Mentioned: “The obesity pay gap is worse than previously thought” by The Economist “The Great Ozempic Experiment” by Julia Belluz Book Recommendations: Behave by Robert M. Sapolsky The Poison Squad by Deborah Blum Ultra-Processed People by Chris van Tulleken Thoughts? Guest suggestions? Email us at [email protected]. You can find transcripts (posted midday) and more episodes of “The Ezra Klein Show” at nytimes.com/ezra-klein-podcast, and you can find Ezra on Twitter @ezraklein. Book recommendations from all our guests are listed at https://www.nytimes.com/article/ezra-klein-show-book-recs. This episode of “The Ezra Klein Show” was produced by Annie Galvin. Fact-checking by Michelle Harris, with Julie Beer. Our senior engineer is Jeff…